Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02947841 · ClinicalTrials.gov registry record · NA
The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients
A NA study of Essential Tremor and Deep Brain Stimulation, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT02947841: Completed NA study of Essential Tremor and Deep Brain Stimulation, sponsored by Oregon Health and Science University.
NCT02947841 is a NA study of Essential Tremor and Deep Brain Stimulation that has completed, run by Oregon Health and Science University. The registered enrollment target is 22 participants, below the 402-participant average among 41 other Essential Tremor trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02947841, a NA study of Essential Tremor and Deep Brain Stimulation, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the hypothesis that alternating DBS parameters on a weekly basis will prevent tolerance to stimulation and thus waning of benefit, compared with non-alternating stimulation. The primary endpoint will be preserved tremor control with the alternating group compared with standard treatment using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS). Key secondary endpoints will be preserved activities of daily living measures as well as preserved tremor control as quantified by motion sensor data. This study has one primary aim: To determine if alternating DBS stimulation parameters on a weekly basis will be superior at preserving tremor control compared with usual stimulation (non-alternating stimulation) in ET patients with VIM DBS.
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Alternating stimulation
Study Locations (1)
Oregon
- Oregon Health Science and University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT02947841 record still lists
NCT02947841 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 402-participant average among 41 other Essential Tremor trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Essential Tremor appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02947841 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT02947841 about?
NCT02947841 is a clinical study titled "The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients". The purpose of this study is to investigate the hypothesis that alternating DBS parameters on a weekly basis will prevent tolerance to stimulation and thus waning of benefit, compared with non-alternating stimulation. The primary endpoint will be preserved tremor control with the alternating group c...
What is the current status of trial NCT02947841?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-10. Estimated completion is 2017-07.
What conditions does trial NCT02947841 study?
This clinical trial studies the following conditions: Essential Tremor, Deep Brain Stimulation.
What interventions are being tested in trial NCT02947841?
The interventions under investigation include: Placebo (OTHER), Alternating stimulation (OTHER).
Who is sponsoring clinical trial NCT02947841?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02947841 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Essential Tremor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02947841's enrollment target sits among peer trials
22 34th of 41 higher than 8 of 41 other Essential Tremor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Essential Tremor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Circadian Adaptive DBS in Essential Tremor
RECRUITING · NA
-
Motor Network Physiology
RECRUITING · NA
-
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
RECRUITING · NA
-
3-D Tractography FUS Ablation for Essential Tremor
RECRUITING · NA
-
Directional Versus Nondirectional DBS for ET
RECRUITING · NA
-
Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia